ARTELO BIOSCIENCES, INC.
For the period ended Jun 30, 2025. Filed Aug 13, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 13, 2025
ARTL$2.07+8.4%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
| ExhibitNumber | Description | Form | File No. | FilingDate | FiledHerewith |
|---|---|---|---|---|---|
| 3.1 | Articles of Incorporation, as amended | 10-Q | 001-38951 | 05/11/2023 | |
| 3.2 | Amended and Restated Bylaws | 8-K | 001-38951 | 04/21/2023 | |
| 10.1 | At-The-Market Offering Agreement, dated July 18, 2025, between Artelo Biosciences, Inc. and R.F. Lafferty & Co., Inc. (incorporated by reference to Exhibit 1.1 to the Company’s Form 8-K filed with the SEC on July 18, 2025) | 8-K | 001-38951 | 07/18/2025 | |
| 10.2 | Securities Purchase Agreement, dated June 24, 2025, between Artelo Biosciences, Inc. and the Purchasers named therein | 8-K | 001-38951 | 06/26/2025 | |
| 10.3 | Form of Subscription Agreement by and between Artelo Biosciences Inc. and the purchasers named therein | 8-K | 001-38951 | 05/01/2025 | |
| 10.4 | Form of Pre-Funded Warrant | 8-K | 001-38951 | 06/26/2025 | |
| 10.5 | Form of $5.82 Warrant | 8-K | 001-38951 | 06/26/2025 | |
| 10.6 | Form of $10.00 Warrant | 8-K | 001-38951 | 06/26/2025 | |
| 10.7 | Form of Convertible Note | 8-K | 001-38951 | 05/01/2025 | |
| 10.8 | Form of Warrant | 8-K | 001-38951 | 05/01/2025 | |
| 31.1 | Section 302 Certification | * | |||
| 32.1 ** | Section 906 Certification | * | |||
| 101. INS | Inline XBRL Instance Document | ||||
| 101. SCH | Inline XBRL Taxonomy Extension Schema Document | ||||
| 101. CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document | ||||
| 101. DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document | ||||
| 101. LAB | Inline XBRL Taxonomy Extension Label Linkbase Document | ||||
| 101. PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document | ||||
| 104 | Cover page Interactive Data File (embedded with the Inline XBRL document) | ||||
| ** | The certification attached as Exhibit 32.1 that accompanies this Quarterly Report on Form 10-Q, is deemed furnished and not filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of Artelo Biosciences, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Quarterly Report on Form 10-Q, irrespective of any general incorporation language contained in such filing. |
|---|
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.